Found: 4
Select item for more details and to access through your institution.
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 6, p. 1274, doi. 10.1093/jac/dkp355
- By:
- Publication type:
- Article
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study.
- Published in:
- Bone Marrow Transplantation, 2010, v. 45, n. 7, p. 1227, doi. 10.1038/bmt.2009.334
- By:
- Publication type:
- Article
Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia Groups.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study.
- Published in:
- Journal of Invasive Fungal Infections, 2010, v. 4, n. 4, p. 151
- By:
- Publication type:
- Article